BenQ Medical Technology Corp. AI Stock Analysis
BenQ Medical Technology Corp. (4116) AI Stock Analysis
BenQ Medical Technology Corp.
(TPEx:4116)
The overall score of 56 reflects a company with a highly attractive valuation and strong dividend yield, offset by significant financial health risks. The primary concern is the combination of collapsing profit margins and a highly leveraged balance sheet, which makes the low P/E ratio a potential value trap. Technicals are neutral, providing no strong directional signal. The high dividend yield and low valuation are the main positive factors, but they are contingent on the company stabilizing its deteriorating fundamentals.
BenQ Medical Technology Corp. (4116) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 1.83B
- Dividend Yield
- 4.91%
- Average Volume (3M)
- 69.94K
- Price to Earnings (P/E)
- 2.4
- Beta (1Y)
- 0.32
- Revenue Growth
- 3.85%
- EPS Growth
- 786.65%
- Country
- TW
- Employees
- 405
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Instruments & Supplies
BenQ Medical Technology Corp. Business Overview & Revenue Model
Company Description
BenQ Medical Technology Corporation operates as a multifaceted entity in the healthcare sector, providing a comprehensive range of services for medical equipment and consumables. This includes their manufacturing, assembly, maintenance, and repair, a...
BenQ Medical Technology Corp. Financial Statement Overview
Summary
Financial performance is under significant pressure. While revenue growth is strong, profitability has deteriorated sharply, with net profit margin collapsing to 1.5% and gross margins declining. The balance sheet is highly leveraged (D/E of 1.77) and returns on equity are weak. Cash flow generation provides a partial offset, but the overall financial health is risky.
Income Statement
42NeutralBalance Sheet
35NegativeCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.44B | 5.25B | 4.77B | 4.54B | 2.95B | 1.46B |
| Gross Profit | 1.69B | 1.69B | 1.45B | 1.34B | 860.25M | 512.28M |
| EBITDA | 622.85M | 611.55M | 618.82M | 624.71M | 476.65M | 166.74M |
| Net Income | 117.69M | 78.17M | 104.83M | 114.58M | 180.24M | 28.84M |
Balance Sheet | ||||||
| Total Assets | 5.52B | 5.45B | 5.27B | 4.71B | 3.40B | 1.96B |
| Cash, Cash Equivalents and Short-Term Investments | 1.03B | 1.24B | 1.19B | 1.15B | 839.46M | 421.27M |
| Total Debt | 2.00B | 1.99B | 1.91B | 1.57B | 852.11M | 491.75M |
| Total Liabilities | 3.24B | 3.12B | 2.97B | 2.53B | 1.66B | 855.51M |
| Stockholders Equity | 1.10B | 1.13B | 1.12B | 1.10B | 1.20B | 1.04B |
Cash Flow | ||||||
| Free Cash Flow | 342.96M | 259.51M | 46.74M | 308.88M | 318.72M | 91.09M |
| Operating Cash Flow | 404.12M | 358.75M | 222.22M | 442.35M | 378.77M | 121.35M |
| Investing Cash Flow | -237.48M | -79.76M | -133.22M | -278.98M | -103.99M | -98.77M |
| Financing Cash Flow | -201.72M | -191.20M | -61.38M | -312.56M | 2.43M | 92.15M |
BenQ Medical Technology Corp. Peers Comparison
Overall Rating
TW:531575Outperform
TW:652773Outperform- TW:411656Neutral
TW:684051Neutral
TW:679640Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| TW:5315 | 75Outperform | TWD 1.85B | 10.66 | ― | 9.04% | 2.53% | 3.36% |
| TW:6527 | 73Outperform | TWD 1.86B | 12.15 | ― | 3.98% | -1.23% | 10.20% |
| TW:4116 | 56Neutral | TWD 1.82B | 2.38 | ― | 4.91% | 3.85% | 786.65% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| TW:6840 | 51Neutral | TWD 2.09B | 40.48 | ― | 1.47% | 13.53% | 65.33% |
| TW:6796 | 40Underperform | TWD 2.04B | 123.00 | ― | 0.51% | 12.26% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4116 | BenQ Medical Technology Corp. | 40.70 | -3.48 | -7.87% | |
| TW:5315 | United Radiant Technology Corporation | 17.70 | -4.63 | -20.73% | |
| TW:6527 | Crystalvue Medical Co Ltd | 72.90 | -5.63 | -7.16% | |
| TW:6796 | Medimaging Integrated Solution Inc. | 49.20 | -40.22 | -44.98% | |
| TW:6840 | BTL, Inc. | 68.00 | 10.10 | 17.45% | |
| TW:7881 | Eyecare Tech, Inc. | 73.20 | -35.89 | -32.90% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026